Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Credit agrmnt [a]
Asset disposition
Inv. presentation
CC transcript
Director departure
Acq. announced
SURGALIGN HOLDINGS, INC. (RTIX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 EFFECT Form EFFECT - Notice of Effectiveness:
10/10/2023 EFFECT Form EFFECT - Notice of Effectiveness:
10/10/2023 EFFECT Form EFFECT - Notice of Effectiveness:
10/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/02/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/02/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
09/29/2023 8-K Asset disposition
Docs: "IN THE UNITED STATES BANKRUPTCY COURT FOR THE SOUTHERN DISTRICT OF TEXAS HOUSTON DIVISION"
08/18/2023 8-K Quarterly results
08/14/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/01/2023 8-K Quarterly results
07/27/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
06/09/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events ...
Docs: "FORM 8-K"
05/11/2023 8-K Quarterly results
Docs: "Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/16/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Cover Page Interactive Data File (embedded within the Inline XBRL document)",
"DEERFIELD, Ill., March 16, 2023 - Surgalign Holdings, Inc., a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it will be hosting its 2023 Annual Meeting of Shareholders virtually, on Thursday, June 1, 2023 at 9 a.m. PT. Shareholders will be able to access the Company's Proxy Statement and Annual Report on Form 10-K once they are filed with the Securities and Exchange Commission. Once filed, both documents will be available on the Company's website. Additionally, your bank, broker, or other organization that holds your Surgalign shares will be issuing proxy materials to you that will include a unique control number. This unique control number will be needed by shareholders in order to access the mee..."
03/06/2023 8-K/A Results of Operations and Financial Condition, Cost Associated with Exit or Disposal Activities, Financial Statements and Exh...
Docs: "FORM 8-K/A",
"Surgalign Provides Update on Corporate Restructuring Initiatives and Confirms its Prior 2022 Revenue Guidance"
03/06/2023 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi...
Docs: "Equity Purchase Agreement between Surgalign Spine Technologies, Surgalign SPV Inc., and Xtant Medical Holdings Inc.",
"CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. INFORMATION THAT HAS BEEN OMITTED HAS BEEN NOTED IN THIS DOCUMENT WITH A PLACEHOLDER IDENTIFIED BY THE MARK “[***]”. TRANSITION SERVICES AGREEMENT"
03/01/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Xtant Medical Acquires Coflex ® Product Line from Surgalign for $17 Million"
02/14/2023 SC 13G ARMISTICE CAPITAL, LLC reports a 10% stake in SURGALIGN HOLDINGS, INC.
12/22/2022 8-K Quarterly results
11/16/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/16/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/15/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
11/15/2022 8-K Quarterly results
11/09/2022 8-K Quarterly results
11/02/2022 8-K Quarterly results
11/02/2022 10-Q Quarterly Report for the period ended September 30, 2022
08/24/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "FORM 8-K",
"Surgalign Announces FDA 510 Clearance of the Cortera TM Spinal Fixation System - The Company's New Flagship Posterior Fixation Platform DEERFIELD, Ill., August 24, 2022 — Surgalign Holdings, Inc., a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced FDA 510 clearance of the Cortera TM Spinal Fixation System. This new flagship product from Surgalign is a key piece to the foundational portfolio designed to drive the company's future growth over the next 10 years and to enable market share gains in the estimated $2.2B US posterior fixation market. “The Cortera system is a testament to the spine engineering talent and expertise we've assembled in very short order, as we moved from zero engineers in the United ..."
08/10/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy